Dian Diagnostics Group Co.,Ltd. (300244.SZ)
CNY 14.03
(1.08%)
CNY 14.03
(1.08%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.33 Billion CNY | -29.07% |
| 2022 | 3.28 Billion CNY | 174.63% |
| 2021 | 1.19 Billion CNY | 79.69% |
| 2020 | 665.64 Million CNY | -37.42% |
| 2019 | 1.06 Billion CNY | -9.94% |
| 2018 | 1.18 Billion CNY | -38.49% |
| 2017 | 1.92 Billion CNY | 78.41% |
| 2016 | 1.07 Billion CNY | 1250.51% |
| 2015 | 79.7 Million CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | -100.0% |
| 2011 | 59.82 Thousand CNY | -90.41% |
| 2010 | 623.93 Thousand CNY | -6.41% |
| 2009 | 666.66 Thousand CNY | -38.11% |
| 2008 | 1.07 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.89 Billion CNY | -16.54% |
| 2024 Q3 | 1.92 Billion CNY | 1.76% |
| 2024 Q1 | 2.26 Billion CNY | -2.6% |
| 2023 FY | 2.33 Billion CNY | -29.07% |
| 2023 Q4 | 2.33 Billion CNY | -11.25% |
| 2023 Q1 | 3.13 Billion CNY | -4.69% |
| 2023 Q3 | 2.62 Billion CNY | -11.25% |
| 2023 Q2 | 2.95 Billion CNY | -5.5% |
| 2022 Q3 | 2.97 Billion CNY | 5.9% |
| 2022 Q1 | 1.82 Billion CNY | 52.24% |
| 2022 FY | 3.28 Billion CNY | 174.63% |
| 2022 Q4 | 3.28 Billion CNY | 10.58% |
| 2022 Q2 | 2.8 Billion CNY | 54.05% |
| 2021 Q3 | 1.11 Billion CNY | 4.11% |
| 2021 Q1 | 836.98 Million CNY | 25.74% |
| 2021 FY | 1.19 Billion CNY | 79.69% |
| 2021 Q4 | 1.19 Billion CNY | 6.97% |
| 2021 Q2 | 1.07 Billion CNY | 28.32% |
| 2020 Q2 | 628.34 Million CNY | -34.65% |
| 2020 Q1 | 961.54 Million CNY | -9.61% |
| 2020 FY | 665.64 Million CNY | -37.42% |
| 2020 Q3 | 704.74 Million CNY | 12.16% |
| 2020 Q4 | 665.64 Million CNY | -5.55% |
| 2019 Q1 | 1.11 Billion CNY | -5.47% |
| 2019 FY | 1.06 Billion CNY | -9.94% |
| 2019 Q2 | 1.52 Billion CNY | 36.18% |
| 2019 Q3 | 1.08 Billion CNY | -28.83% |
| 2019 Q4 | 1.06 Billion CNY | -1.71% |
| 2018 Q3 | 2.18 Billion CNY | 0.26% |
| 2018 Q2 | 2.17 Billion CNY | 15.62% |
| 2018 Q1 | 1.88 Billion CNY | -1.87% |
| 2018 FY | 1.18 Billion CNY | -38.49% |
| 2018 Q4 | 1.18 Billion CNY | -45.93% |
| 2017 FY | 1.92 Billion CNY | 78.41% |
| 2017 Q2 | 1.37 Billion CNY | -0.28% |
| 2017 Q3 | 1.77 Billion CNY | 28.71% |
| 2017 Q1 | 1.38 Billion CNY | 28.47% |
| 2017 Q4 | 1.92 Billion CNY | 8.2% |
| 2016 Q3 | 1.09 Billion CNY | 508.16% |
| 2016 Q1 | 104.7 Million CNY | 31.37% |
| 2016 FY | 1.07 Billion CNY | 1250.51% |
| 2016 Q4 | 1.07 Billion CNY | -1.51% |
| 2016 Q2 | 179.7 Million CNY | 71.63% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q3 | 79.7 Million CNY | 0.0% |
| 2015 Q4 | 79.7 Million CNY | 0.0% |
| 2015 FY | 79.7 Million CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2012 Q2 | - CNY | -100.0% |
| 2012 Q1 | 59.82 Thousand CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 FY | - CNY | -100.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2011 Q3 | 179.48 Thousand CNY | -25.0% |
| 2011 Q4 | 59.82 Thousand CNY | -66.67% |
| 2011 Q2 | 239.31 Thousand CNY | -61.64% |
| 2011 Q1 | 623.93 Thousand CNY | 0.0% |
| 2011 FY | 59.82 Thousand CNY | -90.41% |
| 2010 Q4 | 623.93 Thousand CNY | 0.0% |
| 2010 FY | 623.93 Thousand CNY | -6.41% |
| 2009 FY | 666.66 Thousand CNY | -38.11% |
| 2008 FY | 1.07 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Hangzhou Tigermed Consulting Co., Ltd. | 434.22 Million CNY | -436.628% |
| Dirui Industrial Co.,Ltd. | 3.66 Million CNY | -63444.101% |
| Beijing Strong Biotechnologies, Inc. | 1.13 Billion CNY | -105.907% |
| Medicalsystem Biotechnology Co., Ltd. | 23.59 Million CNY | -9775.27% |
| Maccura Biotechnology Co.Ltd | 175.47 Million CNY | -1227.897% |
| Guangzhou Wondfo Biotech Co.,Ltd | 580.52 Million CNY | -301.386% |
| Guangdong Hybribio Biotech Co.,Ltd. | 28.26 Million CNY | -8142.984% |
| BGI Genomics Co., Ltd. | 283.42 Million CNY | -722.14% |
| Amoy Diagnostics Co., Ltd. | 44.4 Million CNY | -5148.122% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 166.83 Million CNY | -1296.673% |